ArticleProtein & cell2013

Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics.

Yewei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.